In the Literature
The consumption of ultra-processed foods is associated with an increased risk for cancer and cancer-related death, according to findings from a recent study. Read More ›
By Luke Auburn
When it comes to medication adherence for patients, a detailed mathematical analysis from a Rochester Institute of Technology, NY, scientist found that history is likely to repeat itself. Read More ›
Febrile neutropenia (FN) is a serious side effect of many cancer treatments and can lead to severe infection and sepsis with potentially fatal consequences. Read More ›
Biosimilars are poised to bring significant cost-savings opportunities in oncology, while maintaining high-quality patient care. Read More ›
Patients with anemia and lower-risk myelodysplastic syndromes (MDS) in whom first-line erythropoiesis-stimulating agents (ESAs) are not effective generally become transfusion dependent. Read More ›
Lost Earnings from Cancer-Related Deaths Cost the United States $94 Billion in 2015 Read More ›
- Venetoclax plus Rituximab Improves Outcomes in Chronic Lymphocytic Leukemia
- Lay Navigation Reduces Medicare Costs, Resource Utilization
- Adding Antiandrogen Therapy Improves Survival in Recurrent Prostate Cancer
- Gaps in Use of Tyrosine Kinase Inhibitors in Medicare Beneficiaries with Chronic Myeloid Leukemia
- Ricolinostat Shows Promise in Patients with Relapsed or Refractory Multiple Myeloma
- Inotuzumab Ozogamicin Shows Benefit in Acute Lymphoblastic Leukemia
- Adding Daratumumab to Combination Therapy Improves Progression-Free Survival in Patients with Multiple Myeloma
- ASCO Issues Guidelines for Developing Clinical Pathways That Promote Value-Based Care
- Second Cancer Risk Is High After Hodgkin Lymphoma
- Cancer Screening May Not Save Lives, a New Analysis Suggests s
Page 1 of 2
- 1
- 2